This report describes and explains the hormonal supplements market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global hormonal supplements market reached a value of nearly $9.9 billion in 2025, having grown at a compound annual growth rate (CAGR) of 7% since 2020. The market is expected to grow from $9.9 billion in 2025 to $13.61 billion in 2030 at a rate of 6.6%. The market is then expected to grow at a CAGR of 6.1% from 2030 and reach $18.31 billion in 2035.
Growth in the historic period resulted from rising aging population, rising prevalence of hormonal disorders, growth in preventive and wellness healthcare and increasing awareness of hormonal health. Factors that negatively affected growth in the historic period were regulatory restrictions on hormonal products and risk of side effects and safety concerns.
Going forward, growing demand for natural and plant-based supplements, expanding use of hormone replacement therapy (HRT), rise in personalized nutrition and health monitoring and growth of online retail channels will drive the growth. Factors that could hinder the growth of the hormonal supplements market in the future include high cost of advanced or personalized hormone therapy, misuse and ethical concerns and impact of trade war and tariffs.
Market trends for the hormonal supplements market include emphasis on hormone-targeted biotechnology, genomics, and precision medicine, digitalization, cloud computing, big data analytics, and advanced cybersecurity, integrating artificial intelligence (AI) and autonomous intelligence to develop highly personalized hormone-supporting supplement solutions, integrating sustainability, climate technology, and circular economy principles and adopting Industry 4.0 and intelligent manufacturing technologies to create more efficient, precise, and customizable production processes.
The hormonal supplements market is segmented by type into DHEA, estrogen, growth hormone, melatonin, progesterone, testosterone and other types. The estrogen market was the largest segment of the hormonal supplements market segmented by type, accounting for 26.8% or $2.65 billion of the total in 2025. Going forward, the melatonin segment is expected to be the fastest growing segment in the hormonal supplements market segmented by type, at a CAGR of 8.9% during 2025-2030.
The hormonal supplements market is segmented by form into oral, injectable, topical and other forms. The oral market was the largest segment of the hormonal supplements market segmented by form, accounting for 48.6% or $4.81 billion of the total in 2025. Going forward, the injectable segment is expected to be the fastest growing segment in the hormonal supplements market segmented by form, at a CAGR of 6.8% during 2025-2030.
The hormonal supplements market is segmented by application into anti-aging, fertility treatment, hormone replacement therapy, pregnancy support, performance enhancement, sleep aid and other applications. The hormone replacement therapy market was the largest segment of the hormonal supplements market segmented by application, accounting for 31.1% or $3.08 billion of the total in 2025. Going forward, the sleep aid segment is expected to be the fastest growing segment in the hormonal supplements market segmented by application, at a CAGR of 8.5% during 2025-2030.
The hormonal supplements market is segmented by indication into menopause, andropause, sleep, fertility, anti-aging and longevity and others. The sleep market was the largest segment of the hormonal supplements market segmented by indication, accounting for 21.6% or $2.13 billion of the total in 2025. Going forward, the sleep segment is expected to be the fastest growing segment in the hormonal supplements market segmented by indication, at a CAGR of 8.2% during 2025-2030.
The hormonal supplements market is segmented by channel into pharmacy, online, clinics, health stores and institutional. The pharmacy market was the largest segment of the hormonal supplements market segmented by channel, accounting for 35.2% or $3.48 billion of the total in 2025. Going forward, the online segment is expected to be the fastest growing segment in the hormonal supplements market segmented by channel, at a CAGR of 9.7% during 2025-2030.
The hormonal supplements market is segmented by price tier into economy, mid, premium and personalized. The mid market was the largest segment of the hormonal supplements market segmented by price tier, accounting for 36.5% or $3.61 billion of the total in 2025. Going forward, the personalized segment is expected to be the fastest growing segment in the hormonal supplements market segmented by price tier, at a CAGR of 9.1% during 2025-2030.
North America was the largest region in the hormonal supplements market, accounting for 36.6% or $3.62 billion of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the hormonal supplements market will be Asia Pacific and South America where growth will be at CAGRs of 7.8% and 7.6% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 6.4% and 6.2% respectively.
The global hormonal supplements market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 12.68% of the total market in 2024. Nestlé SA (Nature's Bounty, Garden of Life) was the largest competitor with a 2.28% share of the market, followed by Amway Corp. with 1.75%, Herbalife Nutrition Ltd. with 1.58%, GNC Holdings LLC with 1.42%, Life Extension with 1.20%, NOW health Group Inc. with 1.14%, Blackmores Limited with 1.08%, Thorne Healthtech Inc. with 0.91%, Hims & Hers Health Inc. with 0.70% and Metagenics Inc. with 0.63%.
The top opportunities in the hormonal supplements market segmented by type will arise in the melatonin segment, which will gain $1.09 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by form will arise in the oral segment, which will gain $1.78 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by application will arise in the sleep aid segment, which will gain $1.0 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by indication will arise in the sleep segment, which will gain $1.03 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by channel will arise in the online segment, which will gain $1.66 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by price tier will arise in the mid segment, which will gain $1.21 billion of global annual sales by 2030. The hormonal supplements market size will gain the most in the USA at $1.05 billion.
Player-adopted strategies in the hormonal supplements market include focus on the new launches and expanding its operational capabilities through strategic partnerships.
Market-trend-based strategies for the hormonal supplements market include focus on developing innovative solutions, such as menopause-specific hormonal wellness supplements, to support hormonal balance and alleviate symptoms associated with menopause, developing innovative products, such as targeted sleep-support supplements, developing innovating solutions, to support hormonal balance and manage hormone-related conditions such as PCOS, menopause symptoms, and metabolic changes and developing products to support hormonal balance and overall well-being across all life stages.
To take advantage of the opportunities, the analyst recommends the hormonal supplements companies to focus on menopause-specific hormonal supplement expansion and clinical validation, focus on targeted hormone-related sleep support innovation, focus on integrated women’s hormonal wellness and multi-symptom nutraceutical expansion, focus on stage-specific hormonal wellness supplement expansion, focus on ayurvedic phytopharmaceutical hormonal balance solutions, focus on melatonin driven sleep and stress hormonal supplement expansion, focus on injectable hormonal supplement expansion for clinical grade growth, focus on sleep hormonal supplements for circadian and stress-linked demand, focus on personalized hormonal supplementation for precision-driven growth, expand in emerging markets, focus on omnichannel distribution expansion across digital and clinical retail channels, focus on value based tiered pricing strategy for hormonal supplements, focus on digital first education led promotion for hormonal supplements, focus on trust driven multi channel promotion for hormonal wellness brands, focus on sleep aid driven hormonal supplement expansion and focus on online direct-to-consumer channel expansion for hormonal supplements.
This product will be delivered within 3-5 business days.
The global hormonal supplements market reached a value of nearly $9.9 billion in 2025, having grown at a compound annual growth rate (CAGR) of 7% since 2020. The market is expected to grow from $9.9 billion in 2025 to $13.61 billion in 2030 at a rate of 6.6%. The market is then expected to grow at a CAGR of 6.1% from 2030 and reach $18.31 billion in 2035.
Growth in the historic period resulted from rising aging population, rising prevalence of hormonal disorders, growth in preventive and wellness healthcare and increasing awareness of hormonal health. Factors that negatively affected growth in the historic period were regulatory restrictions on hormonal products and risk of side effects and safety concerns.
Going forward, growing demand for natural and plant-based supplements, expanding use of hormone replacement therapy (HRT), rise in personalized nutrition and health monitoring and growth of online retail channels will drive the growth. Factors that could hinder the growth of the hormonal supplements market in the future include high cost of advanced or personalized hormone therapy, misuse and ethical concerns and impact of trade war and tariffs.
Market trends for the hormonal supplements market include emphasis on hormone-targeted biotechnology, genomics, and precision medicine, digitalization, cloud computing, big data analytics, and advanced cybersecurity, integrating artificial intelligence (AI) and autonomous intelligence to develop highly personalized hormone-supporting supplement solutions, integrating sustainability, climate technology, and circular economy principles and adopting Industry 4.0 and intelligent manufacturing technologies to create more efficient, precise, and customizable production processes.
The hormonal supplements market is segmented by type into DHEA, estrogen, growth hormone, melatonin, progesterone, testosterone and other types. The estrogen market was the largest segment of the hormonal supplements market segmented by type, accounting for 26.8% or $2.65 billion of the total in 2025. Going forward, the melatonin segment is expected to be the fastest growing segment in the hormonal supplements market segmented by type, at a CAGR of 8.9% during 2025-2030.
The hormonal supplements market is segmented by form into oral, injectable, topical and other forms. The oral market was the largest segment of the hormonal supplements market segmented by form, accounting for 48.6% or $4.81 billion of the total in 2025. Going forward, the injectable segment is expected to be the fastest growing segment in the hormonal supplements market segmented by form, at a CAGR of 6.8% during 2025-2030.
The hormonal supplements market is segmented by application into anti-aging, fertility treatment, hormone replacement therapy, pregnancy support, performance enhancement, sleep aid and other applications. The hormone replacement therapy market was the largest segment of the hormonal supplements market segmented by application, accounting for 31.1% or $3.08 billion of the total in 2025. Going forward, the sleep aid segment is expected to be the fastest growing segment in the hormonal supplements market segmented by application, at a CAGR of 8.5% during 2025-2030.
The hormonal supplements market is segmented by indication into menopause, andropause, sleep, fertility, anti-aging and longevity and others. The sleep market was the largest segment of the hormonal supplements market segmented by indication, accounting for 21.6% or $2.13 billion of the total in 2025. Going forward, the sleep segment is expected to be the fastest growing segment in the hormonal supplements market segmented by indication, at a CAGR of 8.2% during 2025-2030.
The hormonal supplements market is segmented by channel into pharmacy, online, clinics, health stores and institutional. The pharmacy market was the largest segment of the hormonal supplements market segmented by channel, accounting for 35.2% or $3.48 billion of the total in 2025. Going forward, the online segment is expected to be the fastest growing segment in the hormonal supplements market segmented by channel, at a CAGR of 9.7% during 2025-2030.
The hormonal supplements market is segmented by price tier into economy, mid, premium and personalized. The mid market was the largest segment of the hormonal supplements market segmented by price tier, accounting for 36.5% or $3.61 billion of the total in 2025. Going forward, the personalized segment is expected to be the fastest growing segment in the hormonal supplements market segmented by price tier, at a CAGR of 9.1% during 2025-2030.
North America was the largest region in the hormonal supplements market, accounting for 36.6% or $3.62 billion of the total in 2025. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the hormonal supplements market will be Asia Pacific and South America where growth will be at CAGRs of 7.8% and 7.6% respectively. These will be followed by Western Europe and Eastern Europe where the markets are expected to grow at CAGRs of 6.4% and 6.2% respectively.
The global hormonal supplements market is fairly fragmented, with a large number of small players operating in the market. The top 10 competitors in the market made up 12.68% of the total market in 2024. Nestlé SA (Nature's Bounty, Garden of Life) was the largest competitor with a 2.28% share of the market, followed by Amway Corp. with 1.75%, Herbalife Nutrition Ltd. with 1.58%, GNC Holdings LLC with 1.42%, Life Extension with 1.20%, NOW health Group Inc. with 1.14%, Blackmores Limited with 1.08%, Thorne Healthtech Inc. with 0.91%, Hims & Hers Health Inc. with 0.70% and Metagenics Inc. with 0.63%.
The top opportunities in the hormonal supplements market segmented by type will arise in the melatonin segment, which will gain $1.09 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by form will arise in the oral segment, which will gain $1.78 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by application will arise in the sleep aid segment, which will gain $1.0 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by indication will arise in the sleep segment, which will gain $1.03 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by channel will arise in the online segment, which will gain $1.66 billion of global annual sales by 2030. The top opportunities in the hormonal supplements market segmented by price tier will arise in the mid segment, which will gain $1.21 billion of global annual sales by 2030. The hormonal supplements market size will gain the most in the USA at $1.05 billion.
Player-adopted strategies in the hormonal supplements market include focus on the new launches and expanding its operational capabilities through strategic partnerships.
Market-trend-based strategies for the hormonal supplements market include focus on developing innovative solutions, such as menopause-specific hormonal wellness supplements, to support hormonal balance and alleviate symptoms associated with menopause, developing innovative products, such as targeted sleep-support supplements, developing innovating solutions, to support hormonal balance and manage hormone-related conditions such as PCOS, menopause symptoms, and metabolic changes and developing products to support hormonal balance and overall well-being across all life stages.
To take advantage of the opportunities, the analyst recommends the hormonal supplements companies to focus on menopause-specific hormonal supplement expansion and clinical validation, focus on targeted hormone-related sleep support innovation, focus on integrated women’s hormonal wellness and multi-symptom nutraceutical expansion, focus on stage-specific hormonal wellness supplement expansion, focus on ayurvedic phytopharmaceutical hormonal balance solutions, focus on melatonin driven sleep and stress hormonal supplement expansion, focus on injectable hormonal supplement expansion for clinical grade growth, focus on sleep hormonal supplements for circadian and stress-linked demand, focus on personalized hormonal supplementation for precision-driven growth, expand in emerging markets, focus on omnichannel distribution expansion across digital and clinical retail channels, focus on value based tiered pricing strategy for hormonal supplements, focus on digital first education led promotion for hormonal supplements, focus on trust driven multi channel promotion for hormonal wellness brands, focus on sleep aid driven hormonal supplement expansion and focus on online direct-to-consumer channel expansion for hormonal supplements.
This product will be delivered within 3-5 business days.
Table of Contents
1 Executive Summary
6 Market Characteristics
8 Global Hormone Supplements Market Attractiveness Scoring and Analysis
9 Hormonal Supplements Market, Supply Chain Analysis
10 Major Market Trends
11 Hormonal Supplements Growth Analysis and Strategic Analysis Framework
12 Global Hormonal Supplements Market Size and Growth Analysis
13 Global Hormone Supplements Total Addressable Market (TAM) Analysis
14 Global Hormonal Supplements Market Segmentation
15 Hormonal Supplements Market, Regional and Country Analysis
16 Asia-Pacific Market
17 South East Asia Market
18 North America Market
19 Western Europe Market
20 South America Market
21 Eastern Europe Market
22 Middle East Market
23 Africa Market
24 Competitive Landscape and Company Profiles
25 Other Major and Innovative Companies
28 Hormonal Supplements Market - Company Scoring Matrix
30 Key Mergers and Acquisitions
31 Recent Developments in Hormonal Supplements Market
32 Opportunities and Strategies
33 Hormonal Supplements Market, Conclusions and Recommendations
34 Appendix
Executive Summary
Hormonal Supplements Global Market Opportunities and Strategies to 2035 provides the strategists; marketers and senior management with the critical information they need to assess the global hormonal supplements market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for hormonal supplements? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The hormonal supplements market global report answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider hormonal supplements; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segments, key products, supply chain and market attractiveness scoring and analysis.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future technologies and developments in the market.
- Growth Analysis and Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Regional and Country Analysis - Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each segment by type, by form, by application, by indication, by channel and by price tier in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size and Growth - Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major and Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard - Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
- Recent Developments Information on recent developments in the market covered in the report.
-Market Opportunities and Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations - This section includes recommendations for hormonal supplements providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Type: DHEA; Estrogen; Growth Hormone; Melatonin; Progesterone; Testosterone; Other Types
2) By Form: Oral; Injectable; Topical; Other Forms
3) By Application: Anti-Aging; Fertility Treatment; Hormone Replacement Therapy; Pregnancy Support; Performance Enhancement; Sleep Aid; Other Applications
4) By Indication: Menopause Andropause; Sleep; Fertility; Anti-Aging and Longevity; Others
5) By Channel: Pharmacy; Online; Clinics; Health Stores; Institutional
6) By Price Tier: Economy; Mid; Premium; Personalized
Companies Mentioned: Nestlé SA (Nature's Bounty, Garden of Life); Amway Corp.; Herbalife Nutrition Ltd.; GNC Holdings LLC; Life Extension
Countries: China; Australia; India; Indonesia; Taiwan; Japan; South Korea; USA; Germany; Italy; Spain; UK; France; Russia
Regions: Asia-Pacific; Western Europe; South East Asia; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; hormonal supplements indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Nestlé SA (Nature's Bounty, Garden of Life)
- Amway Corp.
- Herbalife Nutrition Ltd.
- GNC Holdings LLC
- Life Extension
- NOW health Group Inc.
- Blackmores Limited
- Thorne Healthtech Inc.
- Hims & Hers Health Inc.
- Metagenics Inc.
- Otsuka Pharmaceutical
- Kobayashi Pharmaceutical
- DHC
- Asahi Group
- Yuhan Corporation
- Chong Kun Dang Healthcare (CKDHC)
- Korea Ginseng Corp
- Laiqa Wellness Private Limited
- Girlyveda Private Limited
- Miror Therapeutics Private Limited
- Aurelle Health
- Ovum
- Bayer AG
- Standard Process Inc.
- Natural Factors Inc.
- Terry Naturally
- Vitabiotics Ltd.
- HorminaCare Corp
- New Chapter Inc.
- Gaia Herbs Inc.
- Jarrow Formulas Inc.
- DITTO
- Health & Her
- GlaxoSmithKline plc (GSK)
- Perrigo Company plc
- Glanbia plc
- Sanofi S.A.
- Besins Healthcare
- Teva Pharmaceutical Industries
- Tabuk Pharmaceuticals Manufacturing Company
- Jamjoom Pharmaceuticals Company
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 553 |
| Published | June 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 9.9 Billion |
| Forecasted Market Value ( USD | $ 18.31 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 41 |
